TY - JOUR
T1 - Dimensionality and Reliability of the Central Sensitization Inventory in a Pooled Multicountry Sample
AU - Cuesta-Vargas, Antonio I.
AU - Neblett, Randy
AU - Chiarotto, Alessandro
AU - Kregel, Jeroen
AU - Nijs, Jo
AU - van Wilgen, C. Paul
AU - Pitance, Laurent
AU - Knezevic, Aleksandar
AU - Gatchel, Robert J.
AU - Mayer, Tom G.
AU - Viti, Carlotta
AU - Roldan-Jiménez, Cristina
AU - Testa, Marco
AU - Caumo, Wolnei
AU - Jeremic-Knezevic, Milica
AU - Luciano, Juan V.
PY - 2018/3
Y1 - 2018/3
N2 - Central sensitization (CS) involves the amplification of neural signaling within the central nervous system, which evokes pain hypersensitivity. The Central Sensitization Inventory (CSI) assesses 25 overlapping health-related symptom dimensions that have been reported to be associated with CS-related disorders. Previous studies have reported satisfactory test-retest reliability and internal consistency, but factor analyses have exhibited conflicting results in different language versions. The purpose of this cross-sectional study was to thoroughly examine the dimensionality and reliability of the CSI, with pooled data from 1,987 individuals, collected in several countries. The principal component analysis suggested that 1 general factor of CS best described the structure. A subsequent confirmatory factor analysis revealed that a bifactor model, which accounted for the covariance among CSI items, with regard to 1 general factor and 4 orthogonal factors, fit the CSI structure better than the unidimensional and the 4-factor models. Additional analyses indicated substantial reliability for the general factor (ie, Cronbach α =.92; ω =.95; and ω hierarchical =.89). Reliability results for the 4 specific factors were considered too low to be used for subscales. The results of this study clearly suggest that only total CSI scores should be used and reported. Perspective: As far as we know, this is the first study that has examined the factor structure and reliability of the CSI in a large multicountry sample. The CSI is currently considered the leading self-report measure of CS-related symptoms worldwide.
AB - Central sensitization (CS) involves the amplification of neural signaling within the central nervous system, which evokes pain hypersensitivity. The Central Sensitization Inventory (CSI) assesses 25 overlapping health-related symptom dimensions that have been reported to be associated with CS-related disorders. Previous studies have reported satisfactory test-retest reliability and internal consistency, but factor analyses have exhibited conflicting results in different language versions. The purpose of this cross-sectional study was to thoroughly examine the dimensionality and reliability of the CSI, with pooled data from 1,987 individuals, collected in several countries. The principal component analysis suggested that 1 general factor of CS best described the structure. A subsequent confirmatory factor analysis revealed that a bifactor model, which accounted for the covariance among CSI items, with regard to 1 general factor and 4 orthogonal factors, fit the CSI structure better than the unidimensional and the 4-factor models. Additional analyses indicated substantial reliability for the general factor (ie, Cronbach α =.92; ω =.95; and ω hierarchical =.89). Reliability results for the 4 specific factors were considered too low to be used for subscales. The results of this study clearly suggest that only total CSI scores should be used and reported. Perspective: As far as we know, this is the first study that has examined the factor structure and reliability of the CSI in a large multicountry sample. The CSI is currently considered the leading self-report measure of CS-related symptoms worldwide.
KW - central sensitivity syndrome, chronic pain, psychometrics
KW - central sensitization
KW - Central Sensitization Inventory
KW - multicountry sample
UR - http://www.scopus.com/inward/record.url?scp=85041536833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041536833&partnerID=8YFLogxK
U2 - 10.1016/j.jpain.2017.11.006
DO - 10.1016/j.jpain.2017.11.006
M3 - Article
AN - SCOPUS:85041536833
SN - 1526-5900
VL - 19
SP - 317
EP - 329
JO - Journal of Pain
JF - Journal of Pain
IS - 3
ER -